Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Erectile Dysfunction Treatment Drugs Market Portraiture
2.1.1. Global Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2016 (US$ Mn)
2.1.2. Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2016 Vs. 2025 (Value %)
Chapter 3. Erectile Dysfunction Treatment Drugs: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Erectile Dysfunction: Epidemiology
3.3. Erectile Dysfunction Treatment Drugs: Future Trends
3.4. Drivers
3.5. Challenges
3.6. Opportunities
3.7. Attractive Investment Proposition, by Geography, 2016
3.8. Major Agreements, Partnerships and Collaborations
3.9. Competitive Landscape
3.9.1. Competitive Landscape, by Key Players, 2016
Chapter 4. Global Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Erectile Dysfunction Treatment Drugs Market, by Drug Type
4.2. Phosphodiesterase Type 5 Inhibitors (PDE5 Inhibitors)
4.2.1. Sildenafil (Viagra)
4.2.2. Tadalafil (Adcirca, Cialis)
4.2.3. Vardenafil (Levitra, Staxyn)
4.2.4. Avanafil (Stendra)
4.3. Prostaglandin E1
4.3.1. Alprostadil (Caverject, Edex, Muse, Prostin VR Pediatric)
4.4. Others
Chapter 5. Global Erectile Dysfunction Treatment Drugs Market: Pipeline Analysis
5.1. Overview
5.2. Phase III (Market estimations by 2025)
5.2.1. HCP 1302 (Hanmi Pharmaceutical)
5.3. Phase II (Qualitative Information)
5.4. Phase I (Qualitative Information)
Chapter 6. Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.2.1. North America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.2.2.1. U.S.
6.2.2.2. Canada
6.3. Europe Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.3.1. Europe Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.3.2.1. U.K.
6.3.2.2. Germany
6.3.2.3. Rest of Europe
6.4. Asia Pacific Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.4.2.1. Japan
6.4.2.2. China
6.4.2.3. India
6.4.2.4. Rest of APAC
6.5. Latin America Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.5.1. Latin America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.5.2.1. Brazil
6.5.2.2. Mexico
6.5.2.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.6.1. MEA Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Erectile Dysfunction Treatment Drugs Market, by Region, 2015 – 2025 (US$ Mn)
6.6.2.1. GCC
6.6.2.2. South Africa
6.6.2.3. Rest of MEA
Chapter 7. Company Profiles
7.1. Apricus Biosciences
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Bayer AG
7.3. Dong-A Pharmaceutical Co. Ltd
7.4. Eli Lilly and Company
7.5. Johnson & Johnson Services
7.6. Meda Pharmaceuticals
7.7. Pfizer Inc.
7.8. Vivus, Inc.
List of Figures
FIG. 1 Erectile Dysfunction Treatment Drugs: Market Segmentation
FIG. 2 Global Erectile Dysfunction Treatment Drugs Market Share, by Drug Type, 2016 (US$ Mn)
FIG. 3 Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2016 Vs. 2025 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography, 2016
FIG. 5 Market Competition Landscape, by Key Players, 2016
FIG. 6 Global Phosphodiesterase Type 5 Inhibitors (PDE5 Inhibitors) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 7 Global Sildenafil (Viagra) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 8 Global Tadalafil (Adcirca, Cialis) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 9 Global Vardenafil (Levitra, Staxyn) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 10 Global Avanafil (Stendra) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 11 Global Prostaglandin E1 Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 12 Global Alprostadil (Caverject, Edex, Muse, Prostin VR Pediatric) Market in Erectile Dysfunction
Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 13 Global Others Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 14 U.S. Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 15 Canada Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 16 U.K. Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 17 Germany Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 18 Rest Of Europe Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 20 China Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 21 India Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest Of Asia Pacific Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 23 Brazil Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 24 Mexico Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest Of Latin America Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 26 GCC Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 27 South Africa Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest Of Middle East And Africa Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
List of Tables
TABLE 1 Global Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 3 North America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 4 North America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 5 Europe Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 8 Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Latin America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 10 Latin America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Middle East And Africa Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 12 Middle East And Africa Erectile Dysfunction Treatment Drugs Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 13 Apricus Biosciences: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 14 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 15 Dong-A Pharmaceutical Co. Ltd: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 Johnson & Johnson Services: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 Meda Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Vivus, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)